← FDA DRUG APPROVALS

FDA ANDA · ANDA210558

ISOSULFAN BLUE

Sponsor: SOMERSET THERAPS LLC

APPLICATION
ANDA210558
TYPE
ANDA
ORIGINAL APPROVAL
2019-07-12
LATEST ACTION
2019-07-12
ROUTE
SUBCUTANEOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

ISOSULFAN BLUEPrescription
ISOSULFAN BLUE 50MG/5ML (10MG/ML) · SOLUTION · SUBCUTANEOUS

Approval history

2019-07-12UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →